Download image:

Elizabeth B. Andrews

Vice President, Pharmacoepidemiology and Risk Management, RTI-HS

Elizabeth Andrews, PhD, is the vice president of Pharmacoepidemiology and Risk Management at RTI Health Solutions. Dr. Andrews provides consultation for pharmaceutical companies and the U.S. Food and Drug Administration on therapeutic risk management and pharmacoepidemiology, and she directs research programs that evaluate drug safety and compliance with prescribing and treatment guidelines. She oversees the conduct of large, prospective patient registries, web-based surveys, and studies using large existing databases. Dr. Andrews has worked extensively in the areas of HIV and sexually transmitted diseases, birth defects and neonatal health, asthma and chronic obstructive pulmonary disease, and irritable bowel syndrome. She is a fellow and past president of the International Society for Pharmacoepidemiology, and coeditor of Pharmacovigilance. She is an adjunct associate professor of the University of North Carolina School of Public Health and School of Pharmacy, and a member of the Scientific Advisory Board Observational Medical Outcomes Partnership.


PhD, Epidemiology, University of North Carolina at Chapel Hill; MPH, Health Policy and Administration, University of North Carolina at Chapel Hill.

Latest Publications

Drug safety in pregnancy
Andrews, E.B. & Moore, N. (Eds.) (Jun 2014)
Ethical oversight, consent, and confidentiality
Andrews, E.B. & Moore, N. (Eds.) (Jun 2014)
Neurological adverse events
Andrews, E.B. & Moore, N. (Eds.) (Jun 2014)
Forteo Voluntary Patient Registry: 4-Year Progress on A Prospective Osteosarcoma Surveillance Study — Osteoporosis International
Krohn, K., Kellier, N., Masica, D., Gilsenan, A., Harding, A., & Andrews, E. (Feb 2014)
Post-Marketing Case Series Study of Adult Osteosarcoma and For(S)Teo: Study Findings from the First 9 Years — Osteoporosis International
Krohn, K., Kellier, N., Masica, D., Midkiff, K., Harris, D., & Andrews, E. (Feb 2014)
View all publications by Elizabeth B. Andrews (125)


  • Drug Safety
  • Therapeutic Risk Management
  • Therapeutic Outcomes and Safety